Global and USA Point of Care Diagnostic Devices Market Insights, Forecast to 2027

Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Market Analysis and Insights: Global and USA Point of Care Diagnostic Devices Market
This report focuses on global and USA Point of Care Diagnostic Devices market.
In 2020, the global Point of Care Diagnostic Devices market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In USA the Point of Care Diagnostic Devices market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Point of Care Diagnostic Devices Scope and Market Size
Point of Care Diagnostic Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Diagnostic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For USA market, this report focuses on the Point of Care Diagnostic Devices market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in USA.

Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing

Segment by Application
Clinics
Hospitals
Laboratory
Others

By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Abbott
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech